ERBB2 and breast cancer: Remarkably, high SK1 mRNA expression levels were observed to be significantly associated with better prognosis for patients with luminal A (Fig 5B) and luminal B (Fig 5C) and HER2+ (Fig 5D) breast cancer subtypes.